Quach and colleagues121 reported that while the inhibition of the glypican-1 (GPC-1) prostate cancer biomarker decreases cell growth and migration in vitro of the aggressive prostate cancer cell line PC-3, quite surprisingly it increases the PC-3 tumor size in NCr nude mice xenografts. This evidence concerns the gene GPC1 and prostate carcinoma.